Health knowledge made personal
Join this community!
› Share page:

is there a Pepcid Complete recall? We are unable to find it in the usual locations

Posted by sknemne1

Answers (2)
Sort by: Newest first | Oldest first

From the PEPCID site:

 "Johnson & Johnson • Merck Consumer Pharmaceuticals, Co. (JJMCP) is initiating a voluntary recall of one lot of PEPCID® COMPLETE®, lot number BEF062, and one lot of ORIGINAL STRENGTH PEPCID® AC®, lot number BFF010, from the wholesaler and retailer level. This is not a consumer level recall and the risk of a serious adverse health consequence is remote. The recall is being initiated because the potential exists for a small number of bottles within these two lots to have been punctured during the packaging process. The puncture was discovered as part of the company’s quality control processes."

I've noticed not being able to find any of this product either, and the actual recall seems far more limited than the result I'm seeing on the store shelves. 

FDA uncovers more problems at J&J Fort Washington plant

WASHINGTON (Reuters) – U.S. inspectors are still uncovering a host of problems at a Johnson & Johnson manufacturing plant that was the source of a major recall of dozens of popular children's medications earlier this year.

In an inspection report released late on Wednesday, the Food and Drug Administration said a recent visit uncovered multiple  quality control problems, including a failure to properly handle customer complaints.

Inspectors also found "a failure to thoroughly review any unexplained discrepancy" in batches of products and a lack of proper record keeping, according to the report from an inspection that ran from October 27 to December 9.

The plant in Fort Washington, Pennsylvania, has been closed since April.

The FDA is reviewing the inspectors' findings, FDA spokesman Christopher Kelly said. "The agency is not currently in a position to make conclusions regarding their significance," he said.

In a statement, J&J's  McNeil Consumer Healthcare unit said it had been "working diligently to ensure that our manufacturing operations meet the level of quality that consumers and the FDA expect of us."

"While the company has made progress toward that goal, this is an ongoing commitment and we will invest all necessary resources in order to achieve it," McNeil said.

McNeil has recalled a string of products, and the quality control problems have drawn attention from U.S. authorities and Congress, hurt sales and tarnished J&J's reputation.

Last week, the company recalled Softchews Rolaids antacids after consumers reported finding wood and metal bits in the tablets. Other recalls have involved  children's Tylenol, heartburn medicine Mylanta and other products.

The FDA also has cited problems at a J&J plant in Puerto Rico.

Investigations and the recalls themselves have grabbed investor attention as sales take a hit and executives depart. In October, J&J said sales of its consumer products fell 25 percent.

Earlier on Wednesday, the company announced leadership changes that include new oversight of its consumer group at the chairman's office.

FDA released the latest inspection report on its website at http:/

Johnson & Johnson shares closed down 0.3 percent at $62.57 on the New York Stock Exchange.

(Reporting by Susan Heavey and Lisa Richwine; Editing by Tim Dobbyn, Phil Berlowitz)

NOTICE: The information provided on this site is not a substitute for professional medical advice, diagnosis, or treatment. Never delay or disregard seeking professional medical advice from your physician or other qualified health provider because of something you have read on Wellsphere. If you have a medical emergency, call your doctor or 911 immediately.
Post an answer
Write a comment: